World Library  
Flag as Inappropriate
Email this Article

Osteocalcin

Article Id: WHEBN0004994478
Reproduction Date:

Title: Osteocalcin  
Author: World Heritage Encyclopedia
Language: English
Subject: Vitamin K, Gelsolin, Cholecystokinin, Osteoblast, AP-1 transcription factor
Collection:
Publisher: World Heritage Encyclopedia
Publication
Date:
 

Osteocalcin

Bone gamma-carboxyglutamate (gla) protein
PDB rendering based on 1q8h.
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
Symbols  ; BGP; OC; OCN
External IDs GeneCards:
Orthologs
Species Human Mouse
Entrez
Ensembl
UniProt
RefSeq (mRNA)
RefSeq (protein)
Location (UCSC)
PubMed search
Not to be confused with Osteonectin or Osteopontin.

Osteocalcin, also known as bone gamma-carboxyglutamic acid-containing protein (BGLAP), is a noncollagenous protein found in bone and dentin. Because it has gla domains, its synthesis is vitamin K dependent. In humans, the osteocalcin is encoded by the BGLAP gene.[1][2] Its receptor is GPRC6A.[3]

Contents

  • Function 1
  • Use as a biochemical marker for bone formation 2
  • References 3
  • Further reading 4
  • External links 5

Function

Osteocalcin is secreted solely by osteoblasts and thought to play a role in the body's metabolic regulation and is pro-osteoblastic, or bone-building, by nature.[4] It is also implicated in bone mineralization and calcium ion homeostasis. Osteocalcin acts as a hormone in the body, causing beta cells in the pancreas to release more insulin, and at the same time directing fat cells to release the hormone adiponectin, which increases sensitivity to insulin.[4]

Osteocalcin acts on Leydig cells of the testis to stimulate testosterone biosynthesis and therefore affect male fertility.[5]

Use as a biochemical marker for bone formation

As osteocalcin is produced by osteoblasts, it is often used as a marker for the bone formation process. It has been observed that higher serum-osteocalcin levels are relatively well correlated with increases in bone mineral density (BMD) during treatment with anabolic bone formation drugs for osteoporosis, such as Teriparatide. In many studies, osteocalcin is used as a preliminary biomarker on the effectiveness of a given drug on bone formation. For instance, one study which aimed to study the effectiveness of a glycoprotein called lactoferrin on bone formation used osteocalcin as a measure of osteoblast activity.[6]

References

  1. ^ Puchacz E, Lian JB, Stein GS, Wozney J, Huebner K, Croce C (May 1989). "Chromosomal localization of the human osteocalcin gene". Endocrinology 124 (5): 2648–50.  
  2. ^ Cancela L, Hsieh CL, Francke U, Price PA (Sep 1990). "Molecular structure, chromosome assignment, and promoter organization of the human matrix Gla protein gene". The Journal of Biological Chemistry 265 (25): 15040–8.  
  3. ^ Pi M, Wu Y, Quarles LD (Jul 2011). "GPRC6A mediates responses to osteocalcin in β-cells in vitro and pancreas in vivo". Journal of Bone and Mineral Research 26 (7): 1680–1683.  
  4. ^ a b Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G (Aug 2007). "Endocrine regulation of energy metabolism by the skeleton". Cell 130 (3): 456–69.  
  5. ^ Karsenty G, Oury F (Jan 2014). "Regulation of male fertility by the bone-derived hormone osteocalcin". Molecular and Cellular Endocrinology 382 (1): 521–6.  
  6. ^ Bharadwaj S, Naidu AG, Betageri GV, Prasadarao NV, Naidu AS (Sep 2009). "Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women". Osteoporosis International 20 (9): 1603–11.  

Further reading

  • Kamdem LK, Hamilton L, Cheng C, Liu W, Yang W, Johnson JA, Pui CH, Relling MV (Jun 2008). "Genetic predictors of glucocorticoid-induced hypertension in children with acute lymphoblastic leukemia". Pharmacogenetics and Genomics 18 (6): 507–14.  
  • Lin GT, Tseng HF, Chang CK, Chuang LY, Liu CS, Yang CH, Tu CJ, Wang EC, Tan HF, Chang CC, Wen CH, Chen HC, Chang HW (Feb 2008). "SNP combinations in chromosome-wide genes are associated with bone mineral density in Taiwanese women". The Chinese Journal of Physiology 51 (1): 32–41.  
  • Lumachi F, Camozzi V, Tombolan V, Luisetto G (Sep 2009). "Bone mineral density, osteocalcin, and bone-specific alkaline phosphatase in patients with insulin-dependent diabetes mellitus". Annals of the New York Academy of Sciences. 1173 Suppl 1: E64–7.  
  • Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T (Sep 2009). "Serum osteocalcin/bone-specific alkaline phosphatase ratio is a predictor for the presence of vertebral fractures in men with type 2 diabetes". Calcified Tissue International 85 (3): 228–34.  
  • Makita N, Suzuki M, Asami S, Takahata R, Kohzaki D, Kobayashi S, Hakamazuka T, Hozumi N (Apr 2008). "Two of four alternatively spliced isoforms of RUNX2 control osteocalcin gene expression in human osteoblast cells". Gene 413 (1-2): 8–17.  
  • Desbois C, Karsenty G (Mar 1995). "Osteocalcin cluster: implications for functional studies". Journal of Cellular Biochemistry 57 (3): 379–83.  
  • Salem AM, Zohny SF, Abd El-Wahab MM, Hamdy R (Nov 2007). "Predictive value of osteocalcin and beta-CrossLaps in metastatic breast cancer". Clinical Biochemistry 40 (16-17): 1201–8.  
  • Im JA, Yu BP, Jeon JY, Kim SH (Oct 2008). "Relationship between osteocalcin and glucose metabolism in postmenopausal women". Clinica Chimica Acta; International Journal of Clinical Chemistry 396 (1-2): 66–9.  
  • Ba Y, Huang H, Yang Y, Cui L, Zhu J, Zhu C, Liu J, Zhang Y (Nov 2009). "The association between osteocalcin gene polymorphism and dental fluorosis among children exposed to fluoride in People's Republic of China". Ecotoxicology and Environmental Safety 72 (8): 2158–61.  
  • Hwang YC, Jeong IK, Ahn KJ, Chung HY (Nov 2009). "The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects". Diabetes/Metabolism Research and Reviews 25 (8): 768–72.  
  • Yerges LM, Klei L, Cauley JA, Roeder K, Kammerer CM, Moffett SP, Ensrud KE, Nestlerode CS, Marshall LM, Hoffman AR, Lewis C, Lang TF, Barrett-Connor E, Ferrell RE, Orwoll ES, Zmuda JM (Dec 2009). "High-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older men". Journal of Bone and Mineral Research 24 (12): 2039–49.  
  • Yu S, Jiang Y, Galson DL, Luo M, Lai Y, Lu Y, Ouyang HJ, Zhang J, Xiao G (Feb 2008). "General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2". The Journal of Biological Chemistry 283 (9): 5542–53.  
  • Kayed H, Bekasi S, Keleg S, Michalski CW, Giese T, Friess H, Kleeff J (2007). "BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion". Molecular Cancer 6: 83.  
  • French D, Hamilton LH, Mattano LA, Sather HN, Devidas M, Nachman JB, Relling MV (May 2008). "A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group". Blood 111 (9): 4496–9.  
  • Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B (Mar 2009). "Association between serum osteocalcin and markers of metabolic phenotype". The Journal of Clinical Endocrinology and Metabolism 94 (3): 827–32.  
  • Kindblom JM, Ohlsson C, Ljunggren O, Karlsson MK, Tivesten A, Smith U, Mellström D (May 2009). "Plasma osteocalcin is inversely related to fat mass and plasma glucose in elderly Swedish men". Journal of Bone and Mineral Research 24 (5): 785–91.  
  • Wahlgren CM, Zheng W, Shaalan W, Tang J, Bassiouny HS (2009). "Human carotid plaque calcification and vulnerability. Relationship between degree of plaque calcification, fibrous cap inflammatory gene expression and symptomatology". Cerebrovascular Diseases 27 (2): 193–200.  
  • Lumachi F, Ermani M, Camozzi V, Tombolan V, Luisetto G (Sep 2009). "Changes of bone formation markers osteocalcin and bone-specific alkaline phosphatase in postmenopausal women with osteoporosis". Annals of the New York Academy of Sciences. 1173 Suppl 1: E60–3.  
  • Born AK, Rottmar M, Lischer S, Pleskova M, Bruinink A, Maniura-Weber K (2009). "Correlating cell architecture with osteogenesis: first steps towards live single cell monitoring". European Cells & Materials 18: 49–60, 61–2; discussion 60.  
  • Fujisawa R (Mar 2002). "[Recent advances in research on bone matrix proteins]". Nihon Rinsho. Japanese Journal of Clinical Medicine. 60 Suppl 3: 72–8.  

External links

This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and USA.gov, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for USA.gov and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
 
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
 
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.
 


Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.